Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыДефектологияКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинШкольникамКарта сайта

Поздравляем!
Поздравляем нового Логобуржца Фарида со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Ruthenium Compounds as Antineoplastic agents   Sreekanth Thota,Rajeshwar Yerra and S. S. Karki

Ruthenium Compounds as Antineoplastic agents

100 страниц. 2014 год.
LAP Lambert Academic Publishing
Whilst the chemotherapeutic success of platinum is undeniable, it is by no means the perfect drug. It is not effective against many common types of cancer, drug resistance is common and it has a deplorable range of side effects, which can include nerve damage, hair loss and nausea. To overcome these limitations, some compounds based on ruthenium have been developed and tested against cancer cell lines. These compounds tend to cause fewer side effects compared to platinum drugs. Ruthenium compounds represent one of the great success stories of metals in medicine. Two ruthenium compounds are currently undergoing clinical evaluation as anticancer drugs NAMI-A and KP1019. A great deal of the remaining ruthenium complexes, these efforts are continue today with increased realization that new strategies are needed to overcome issues of toxicity and resistances inherent treatment by the ruthenium anticancer agents. The present study deals with the new strategies for the development of novel...
 
- Генерация страницы: 0.03 секунд -